With increasing regulatory restrictions on animal testing and growing expectations for safer, more sustainable products, the cosmetics and personal care industry must adopt innovative approaches to safety assessment. Skin sensitization remains a critical toxicological endpoint, particularly as global regulations continue to discourage or restrict the use of animal-based testing methods.
In this complimentary webinar, we introduce next-generation integrated strategies for skin sensitization assessment that combine in chemico, in vitro, in silico and weight-of-evidence approaches. These integrated approaches to testing and assessment (IATA) provide a scientifically robust, non-animal framework that aligns with international regulatory expectations while supporting efficient product development.
Attendees will gain practical insight into the biological mechanisms underlying skin sensitization, key alternative testing methods and how relevant data streams can be integrated to support hazard identification and risk assessment for cosmetic ingredients and finished products. Real-world regulatory considerations and case examples will be discussed to illustrate how these strategies can be successfully applied in practice.
This session is designed to help industry professionals improve safety decision-making, enhance regulatory readiness across global markets and accelerate innovation without compromising consumer safety.
Agenda
- Overview of skin sensitization mechanisms
- Key in vitro and in silico methods
- Integrated approaches to testing and assessment (IATA)
- Regulatory perspectives and case studies
- Q&A
Who should attend?
This webinar is designed for toxicologists and cosmetics industry professionals, including manufacturers and quality control managers and regulatory specialists serving the US, EU and Asian markets.
Register now. This webinar takes place on May 28, 2026, at 4:00 pm (CEST).